-
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
Bakker, N. A. M., Garner, H., van Dyk, E., Champanhet, E., Klaver, C., Duijst, M., Voorwerk, L., Nederlof, I., Voorthuis, R., Liefaard, M. C., Nieuwland, M., de Rink, I., Bleijerveld, O. B., Oosterkamp, H. M., Wessels, L. F. A., Kok, M. & de Visser, K. E., 1 Dec 2025, In: npj Breast Cancer. 11, 1, 5.Research output: Contribution to journal › Article* › Academic › peer-review
-
Biomarker-based personalization of breast cancer care: Navigating opportunities and challenges
Liefaard, M. C., 2025, 235 p.Research output: PhD thesis › Thesis, fully internal
-
Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival
van der Voort, A., Liefaard, M. C., van Ramshorst, M. S., van Werkhoven, E., Sanders, J., Wesseling, J., Scholten, A., Vrancken Peeters, M. J. T. F. D., de Munck, L., Siesling, S. & Sonke, G. S., 1 Oct 2022, In: Breast (Edinburgh, Scotland). 65, p. 110-115 6 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
